2-Hydroxyisovaleric Acid

Your cells handle the amino acid leucine through a chain of steps inside mitochondria (the energy-producing parts of your cells), and one of those steps depends on biotin, a B vitamin. When the biotin-powered step slows down, a small acid called 2-hydroxyisovaleric (closely related to, and often reported alongside, 3-hydroxyisovaleric acid) builds up and ends up in your urine. The amount you excrete is a window into how cleanly that pathway is running.

This is a research-grade urine marker, not a standard clinical lab number with a one-size-fits-all cutoff. Used thoughtfully, it can hint at marginal biotin status, smoking-related metabolic effects, or unusual stress on protein breakdown, well before any of those show up on a routine panel.

What the Test Actually Captures

2-hydroxyisovaleric acid is a small organic acid produced when your body processes leucine, one of the three branched-chain amino acids in dietary protein. It comes from the same pathway as the more widely studied 3-hydroxyisovaleric acid (3-HIVA), and labs and research papers sometimes do not separate the two cleanly. Most of the human evidence below was generated for 3-HIVA, a closely related but not identical molecule, and is included here because it tracks the same biology.

The metabolite is made inside mitochondria by an enzyme called 3-methylcrotonyl-CoA carboxylase (3MCC) that requires biotin to function. When 3MCC slows down, more of the upstream acid escapes into the bloodstream and gets filtered into urine. That is why urinary 3-HIVA has been described as a useful marker of biotin status.

Biotin Status and Vitamin-Driven Shifts

In healthy pregnant women, urinary 3-hydroxyisovaleric acid is frequently elevated, a pattern interpreted as marginal biotin deficiency during normal pregnancy. Biotin supplementation in a randomized trial brought the elevated excretion back down, supporting the idea that the metabolite tracks real, modifiable biotin status rather than a fixed trait.

Smoking accelerates biotin breakdown. In women who smoked, urinary 3-hydroxyisovaleric acid was higher, consistent with tissue-level biotin depletion. The takeaway: this marker can pick up on lifestyle exposures that quietly drain a B vitamin most people never think about.

Inborn Errors of Leucine Metabolism

Classic clinical use of urinary 3-hydroxyisovaleric acid is in diagnosing rare inherited disorders of leucine processing. In isovaleric acidemia, the metabolite rises sharply during acute attacks, with urinary excretion peaking about two days after plasma levels. In 3-methylglutaconic aciduria type I, elevated urinary 3-hydroxyisovaleric acid accompanies other leucine-pathway acids. Beta-methylcrotonyl-CoA carboxylase deficiency was first described in part by very high urinary beta-hydroxyisovaleric acid.

These conditions are usually picked up in newborn screening or early childhood. For adults without a known metabolic diagnosis, the test is far more useful as a window into acquired, modifiable factors than as a screen for rare inherited disease.

Kidney Disease

A meta-analysis of metabolomics studies in primary glomerulonephritis (a group of kidney conditions) found that urinary 3-hydroxyisovaleric acid was consistently lower than in controls. The interpretation offered was impaired kidney handling of biotin and a broader disturbance of amino acid and energy metabolism in diseased kidneys.

This finding runs the opposite direction from the elevations seen in pregnancy, smoking, and inflammatory states. The reconciliation is straightforward: urinary 2/3-hydroxyisovaleric acid is not a simple "higher is worse, lower is better" number. It is a context-dependent readout of how leucine and biotin metabolism interact with your kidneys, lungs, and overall metabolic state. A low reading in someone with known kidney disease carries different meaning than a low reading in a healthy adult, and a single value is only useful when interpreted alongside the rest of your clinical picture.

Inflammation and Severe Illness

Urinary 3-hydroxyisovaleric acid is higher in severe pulmonary sarcoidosis than in milder disease, a pattern linked to muscle protein breakdown, low oxygen, and altered branched-chain amino acid handling inside mitochondria. Similar elevations have been reported in Crohn disease and in severe COVID-19 with poor lung function.

Serum 3-hydroxyisovaleric acid (a different specimen than this urine test, though tracking the same molecule) was one of three metabolites in a panel that distinguished early rheumatoid arthritis from controls with about 93.5% sensitivity and 94.4% specificity. That panel slightly outperformed anti-CCP antibodies, a standard rheumatoid arthritis marker. The signal in inflammatory disease appears real, though it is shared with many other conditions and not specific on its own.

Tracking Your Trend

Urinary 3-hydroxyisovaleric acid is highly individual-specific. In healthy children, more than 50% of the variance in this metabolite came from the person rather than day-to-day fluctuation. That means your own baseline is more meaningful than any population reference range, and trends over time will tell you more than any single number.

Get a baseline now. If you are testing in response to a specific concern, such as starting biotin, quitting smoking, or changing your diet, retest in 3 to 6 months. Once you have a stable picture, an annual check is enough for most people who feel well. If your number jumps or drops noticeably between tests, repeat to confirm before drawing any conclusions, since urine metabolites can shift with hydration, recent meals, and collection timing.

What to Do With an Out-of-Pattern Result

If your level looks unusual, treat it as a starting point, not a diagnosis. Pair it with related metabolic and nutritional markers. Vitamin B12, folate, and methylmalonic acid round out the picture of B-vitamin status. A full urine organic acids panel can show whether other leucine-pathway acids are moving in the same direction, which strengthens the signal. A blood acylcarnitine profile is the next step if there is any clinical suspicion of an inherited metabolic condition.

Combine that data with context. Are you pregnant, smoking, taking valproate, or recovering from a serious illness? Each of these can shift the number. Persistent, unexplained elevations alongside symptoms such as recurrent vomiting, neurological changes, or unusual fatigue are worth taking to a metabolic specialist or endocrinologist. A single odd value in someone who feels well, with a known explanation, is usually not actionable on its own.

When Results Can Be Misleading

• Valproate (an anti-seizure medication): blocks the biotin-dependent enzyme that processes leucine and raises urinary 3-hydroxyisovaleric acid. The shift reflects drug interference with biotin handling, not an underlying inherited metabolic disease.
• Pregnancy: routinely raises urinary 3-hydroxyisovaleric acid through marginal biotin deficiency. A higher reading during pregnancy may be physiological rather than a sign of disease.
• Recent acute illness or fever: can shift how mitochondria handle branched-chain amino acids. Wait until you are back to baseline before drawing conclusions from a single reading.
• Collection issues: urine concentration varies with hydration and time of day. First-morning samples and proper handling per your lab's instructions reduce noise in the result.